Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)

NCT04571437 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
204
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cairo University